Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPAT: Early Propranolol in Traumatic Brain Injury
NCT01202110Phase 2Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jun 2010
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of propranolol in traumatic brain injury (TBI) (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Safe Dosing of Early Propranolol at 24 months. Started Jun 2010; status: terminated.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01202110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202110.